Literature DB >> 17097495

Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation.

Cristiano Feijó Andrade1, Hiroyuki Kaneda, Sandy Der, Melanie Tsang, Monika Lodyga, Claudia Chimisso Dos Santos, Shaf Keshavjee, Mingyao Liu.   

Abstract

BACKGROUND: Innate immunity is the first line of host defense against invading microorganisms, which is mediated by specific pathogen recognition molecules called toll-like receptors (TLRs). TLRs can also recognize endogenous "danger" signals, resulting in cytokine production and activation of the adaptive immune system. We hypothesized that gene expression of TLRs during lung transplantation may be affected by the donor condition and the ischemia-reperfusion process, which may subsequently influence graft function.
METHODS: Lung biopsies from 14 patients were collected before and after reperfusion, and mRNA levels of TLRs, cytokines (interleukin [IL]-1beta, IL-6, IL-8, IL-10 and interferon-gamma) and heat-shock protein 70 (HSP70) were measured by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: In cold-preserved donor lungs, all TLRs (except TLR3) showed significant correlations with one another and also with the cytokines examined. Expression of several TLRs and cytokines correlated with the intubation time of donors. TLR4 gene expression correlated closely with IL-8 before and after reperfusion (p </= 0.01). After reperfusion, HSP70 mRNAs increased significantly (p < 0.05).
CONCLUSIONS: Differential expression levels of TLRs and cytokine genes likely reflect the inflammatory status of lung grafts; correlation of TLR genes with cytokine genes and clinical conditions implicates a potential role of TLRs in early graft responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097495     DOI: 10.1016/j.healun.2006.09.017

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  27 in total

1.  Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5.

Authors:  Gang Jee Ko; Douglas Linfert; Hye Ryoun Jang; Elizabeth Higbee; Tonya Watkins; Chris Cheadle; Manchang Liu; Lorraine Racusen; Dmitry N Grigoryev; Hamid Rabb
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

Review 2.  The hypoxia-inflammation link and potential drug targets.

Authors:  Michael Koeppen; Tobias Eckle; Holger K Eltzschig
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

3.  Preprocurement In Situ Donor Lung Tissue Gene Expression Classifies Primary Graft Dysfunction Risk.

Authors:  Edward Cantu; Mengying Yan; Yoshikazu Suzuki; Taylor Buckley; Vito Galati; Neha Majeti; Christian A Bermudez; Joshua M Diamond; Jason D Christie; Rui Feng
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

Review 4.  Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.

Authors:  S Samuel Weigt; Ariss DerHovanessian; W Dean Wallace; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

5.  Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.

Authors:  Stavros Garantziotis; Scott M Palmer; Laurie D Snyder; Tonya Ganous; Benny J Chen; Tie Wang; Donald N Cook; David A Schwartz
Journal:  Transplantation       Date:  2007-10-27       Impact factor: 4.939

Review 6.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

Review 7.  Innate immunity and organ transplantation: focus on lung transplantation.

Authors:  Daniel Kreisel; Daniel R Goldstein
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

8.  Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation.

Authors:  E Cantu; D J Lederer; K Meyer; K Milewski; Y Suzuki; R J Shah; J M Diamond; N J Meyer; J W Tobias; D A Baldwin; V M Van Deerlin; K M Olthoff; A Shaked; J D Christie
Journal:  Am J Transplant       Date:  2013-05-24       Impact factor: 8.086

9.  Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.

Authors:  Barbara C S Hamilton; Gabriela R Dincheva; Hanjing Zhuo; Jeffrey A Golden; Marek Brzezinski; Jonathan P Singer; Michael A Matthay; Jasleen Kukreja
Journal:  Clin Transplant       Date:  2018-02-23       Impact factor: 2.863

10.  Bioluminescence imaging visualizes activation of nuclear factor-kappaB in mouse cardiac transplantation.

Authors:  Lianli Ma; Zhidan Xiang; Taylor P Sherrill; Lei Wang; Timothy S Blackwell; Philip Williams; Anita Chong; Ravi Chari; Deng Ping Yin
Journal:  Transplantation       Date:  2008-03-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.